申请人:NOVO NORDISK A/S
公开号:EP0260467A2
公开(公告)日:1988-03-23
Heterocyclic dihydroxyquinoxaline compounds having the formula
wherein
R¹ is halogen, CN, CF₃, ethynyl, or N₃
and
R² is SO₂C1-3-alkyl, CF₃, NO₂, ethynyl, or CN.
The invention also relates to a method of preparing the compounds, pharmaceutical compositions thereof, and their use.
The compounds are useful in the treatment of indications caused by hyperactivity of the excitatory neurotransmitters, particularly the quisqualate receptors, and especially as neuroleptics.
具有以下式子的杂环二羟基喹喔啉化合物
其中
R¹ 是卤素、CN、CF₃、乙炔基或 N₃
和
R² 是 SO₂C1-3-烷基、CF₃、NO₂、乙炔基或 CN。
本发明还涉及化合物的制备方法、其药物组合物及其用途。
本发明的化合物可用于治疗兴奋性神经递质,特别是喹乙醇受体活性亢进引起的症状,尤其可用作神经抑制剂。